RT Journal Article
SR Electronic
T1 CAIRS: A causal artificial intelligence recommendation system for digital mental health
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.11.11.24317126
DO 10.1101/2024.11.11.24317126
A1 Varidel, Mathew
A1 An, Victor
A1 Hickie, Ian B.
A1 Cripps, Sally
A1 Marchant, Roman
A1 Scott, Jan
A1 Crouse, Jacob J.
A1 Poulsen, Adam
A1 O’Dea, Bridianne
A1 Iorfino, Frank
YR 2024
UL http://medrxiv.org/content/early/2024/12/07/2024.11.11.24317126.abstract
AB Digital mental health tools have the prospect to enhance and expand access to care for those in need. Some tools provide interventional recommendations to individuals, typically using simple static rule-based systems (e.g., if-else statements) or by incorporating predictive artificial intelligence. However, interventional recommendations require a decision based on the comparison of future outcomes under different interventions, which requires causal considerations. Here we develop CAIRS, a causal artificial intelligence recommendation system that provides personalised interventional recommendations using an individual’s current presentation and the learned dynamics between domains to identify and rank intervention targets that have the greatest impact on future outcomes. Our approach was applied to longitudinal data of multiple mental health and related domains at two timepoints (1 week - 6 months from baseline) collected from a digital mental health tool. In our example, psychological distress was found to be the key influential domain that affected multiple domains (e.g., personal functioning, social connection), and thus was typically the preferred target in complex cases where multiple domains were unhealthy. Our approach is broadly applicable to recommendation contexts where causal considerations are important, and the framework could be incorporated within a live app to enhance digital mental health tools.Competing Interest StatementI.B.H. is the Co-Director, Health and Policy at the Brain and Mind Centre (BMC) University of Sydney, Australia. The BMC operates an early-intervention youth service at Camperdown under contract to headspace. I.B.H. has previously led community-based and pharmaceutical industry-supported (Wyeth, Eli Lily, Servier, Pfizer, AstraZeneca, Janssen Cilag) projects focused on the identification and better management of anxiety and depression. I.B.H. is the Chief Scientific Adviser to, and a 3.2% equity shareholder in, InnoWell Pty Ltd which aims to transform mental health services through the use of innovative technologies. All other authors declare no conflict of interest. All other authors declare no financial or non-financial competing interests.Funding StatementThis work was supported by the Medical Research Future Fund National Critical Research Infrastructure Grant (MRFCRI000279), and NHMRC Australia Fellowship (No. 511921 awarded to I.B.H.). M.V. was supported by philanthropic funding from The Johnston Fellowship and from other donor(s) who are families affected by mental illness who wish to remain anonymous. I.B.H. is supported by an NHMRC L3 Investigator Grant (GNT2016346). J.J.C. was supported by a NHMRC Emerging Leadership Fellowship (GNT2008196). F.I. was supported by an NHMRC EL1 Investigator Grant (GNT2018157).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This research activity has been deemed exempt from ethics review under Section 5.1.17(a) of the Australian National Health and Medical Research Council National Statement on Ethical Conduct in Human Research (2023) by The University of Sydney Human Research Ethics Committee.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesData used for this study is available from the corresponding author on reasonable request.